HOME >> BIOLOGY >> NEWS
NYAS China Conference reveals latest advances in biomedical sciences

China has experienced tremendous growth within the past decade. Its economic boom and growing domestic market is now paralleled by its ascendancy in the life sciences, and the countrys scientists are rapidly rising to the cutting edge in areas such as neuroscience, chemical biology, and many other fields.

To share the advances that Chinese scientists have made in the sciences and facilitate increased collaboration and partnership among scientists from the U.S., China, Europe, and other parts of Asia, the New York Academy of Sciences, the Chinese Academy of Sciences and the Shanghai Institutes of Biomedical Sciences recently hosted the groundbreaking Frontiers of Biomedical Sciences conference in Shanghai. This unique meeting brought together noted scientists from China, the U.S., Europe and other parts of Asia to discuss the most pressing issues at the cutting edge of biomedical science.

For a comprehensive online report that covers all of the material presented at this unprecedented conference, go to the Academys website at www.nyas.org/china for the Frontiers in Biomedical Science eBriefing. The report includes an overview; bulleted highlights and summaries encapsulating every major presentation; chapterized, searchable audio presentations, synchronized with speakers slides; links to relevant web sites, books, journal articles; and cross-referenced articles from the Academy on related subjects.

Exciting New Research from East and West
Panel discussions, plenary lectures, and shorter technical talks by leading researchers from China, the United States, and Europe focused on four specific scientific areas: (1) chemical biology (2) infectious diseases (3) genomic medicine, and (4) neuroscience.

The eBriefing reveals the latest research on:

  • Chemical Biology:
    Gregory Verdine, Harvard College professor of chemical biology explained why certain classes of cellular targets previously thought to b
    '"/>


Contact: Jennifer Tang
jtang@nyas.org
212-838-0230
New York Academy of Sciences
31-Jan-2006


Page: 1 2

Related biology news :

1. University of Leeds strengthens China links in membrane and neurobiology
2. Elsevier partners with National Natural Science Foundation of China
3. First systematic study of Chinas one-child policy reveals complexity, effectiveness
4. Nanotechnology key to Chinas future economic success
5. AAAS/EurekAlert! refocus on China with 2007 Fellowships for Science Reporters in Developing Regions
6. Chinas environmental challenges
7. Metals in China: Protecting the environment
8. Metals in China: Protecting the environment
9. NSF grant aids ASU biodiversity exploration in China
10. Yale ovarian cancer detection technology licensed in China by SurExam
11. First analysis of recent disease outbreak in China

Post Your Comments:
(Date:5/18/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)...  Through a well-rounded UAS delegation representing private industry, government, ... showing at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people ... the UAS ecosystem. "Our message is clear ... Aerospace Rich Knoll . "If you want to fly ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
(Date:5/29/2015)... May 29, 2015 Delcath Systems, Inc. ... medical device company focused on oncology with an ... liver cancers, announces that results of a large, ... melanoma patients with hepatic metastases with the Delcath ... in an on-line abstract at the American Society ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences ® ... the promise of precision medicine, today announced the ... the clinical utility of Caris Molecular Intelligence ® ... in helping to identify targeted treatment options for ... of the studies, results of which are to ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Results from ... talimogene laherparepvec and its ability to reduce the size ... have been published in the Journal of Clinical Oncology. ... with stages IIIB, IIIC and IV melanoma, a potentially ... the study was to evaluate the safety and efficacy ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "Alzheimer ...  to their offering.       (Logo: ... challenge in management. With nearly 8 million ... major markets of the world and anticipated ...
Breaking Biology Technology:Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 3
Cached News: